Market Cap: $97.47M
CI
Coya Therapeutics, Inc.
COYA
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $97.47M
Coya Therapeutics Focuses on Innovative Treg-Enhancing Biologics Coya Therapeutics, Inc., a Houston-based biotechnology firm, is at the forefront of developing biologics that enhance regulatory T cell…
Coya Therapeutics Enhances Focus on Treg-based Biologics for Neurodegenerative Diseases Coya Therapeutics, Inc., a Houston-based biotechnology company, is making significant strides in the development…
Coya Therapeutics Advances Innovative Immunomodulatory Therapy COYA 303 Coya Therapeutics, Inc., a Houston-based clinical-stage biotechnology company, is making significant strides in its investigatio…
Coya Therapeutics Advances COYA 303: A Promising Therapeutic for Inflammatory Diseases Coya Therapeutics, Inc., a Houston-based clinical-stage biotechnology company, is making strides in the developme…
Coya Therapeutics Enhances Focus on Treg Function at Upcoming Health Conference Coya Therapeutics, Inc., a clinical-stage biotechnology company based in Houston, is set to showcase its innovative work…
Coya Therapeutics to Showcase Innovative Treg Approach at Evercore HealthCONx Conference Coya Therapeutics, Inc., a Houston-based clinical-stage biotechnology company, prepares to highlight its ground…